Results 31 to 40 of about 32,623 (326)

Persistent Facial Oedema and Erythema in a Woman, An Uncommon Manifestation of Chronic Cutaneous Lupus Erythematosus

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2020
Manifestations of chronic cutaneous lupus erythematosus are variable. Periorbital and facial swelling occurs in dermatomyositis and systemic lupus, but it has been rarely reported as a manifestation of exclusively cutaneous lupus.
Mónica García-Arpa   +4 more
doaj   +1 more source

Photosensitivity in cutaneous lupus erythematosus [PDF]

open access: yesPhotodermatology, Photoimmunology & Photomedicine, 2013
SummaryBackgroundUltraviolet radiation (UVR) is a well‐known exacerbating factor for cutaneous lupus erythematosus (CLE), with photosensitivity comprising one of the American College of Rheumatology (ACR) diagnostic criteria for systemic lupus erythematosus (SLE).
Andrew, Kim, Benjamin F, Chong
openaire   +2 more sources

B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity

open access: yesFrontiers in Immunology, 2021
Cutaneous lupus erythematosus (CLE) is a chronic inflammatory skin disease characterized by a diverse cadre of clinical presentations. CLE commonly occurs in patients with systemic lupus erythematosus (SLE), and CLE can also develop in the absence of ...
Lisa Abernathy-Close   +18 more
doaj   +1 more source

Phototesting and photoprotection in LE [PDF]

open access: yes, 1997
Photosensitivity and induction of skin lesions following UV radiation is a common problem of patients with cutaneous and systemic forms of lupus erythematosus.
Kind, P., Walchner, M., Messer, G.
core   +1 more source

Taxane associated subacute cutaneous lupus erythematosus [PDF]

open access: yes, 2013
Numerous medications have been associated with the development of subacute cutaneous lupus erythematosus. A mechanism explaining how unrelated drug classes can lead to subacute cutaneous lupus erythematosus has remained elusive, suggesting that there may
Marchetti, Michael A.   +3 more
core   +1 more source

Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaire [PDF]

open access: yes, 2015
There is currently no uniform definition of cutaneous lupus erythematosus (CLE) upon which to base a study population for observational and interventional trials.
Goodfield, M. J.   +21 more
core   +1 more source

Immunogenetics of cutaneous lupus erythematosus [PDF]

open access: yesCurrent Opinion in Pediatrics, 2016
Purpose of review Systemic lupus erythematosus (SLE) is the prototypic autoimmune condition, often affecting multiple organ systems, including the skin. Cutaneous lupus erythematosus (CLE) is distinct from SLE and may be skin limited or associated with systemic disease.
Aimee O, Hersh   +2 more
openaire   +2 more sources

Factores asociados al desarrollo de lupus eritematoso sistémico en pacientes con lupus cutáneo [PDF]

open access: yes, 2020
Importance: Up to 28% of patients with cutaneous lupus erythematosus (CLE) develop systemic lupus erythematosus (SLE). Studies aimed at identifying additional risk factors for progression to systemic disease are scarce and in the case of Latin America ...
Berrío Flórez, Paula Gabriela
core   +1 more source

Pathophysiology of cutaneous lupus erythematosus [PDF]

open access: yesArthritis Research & Therapy, 2015
AbstractThe pathophysiology of cutaneous lupus erythematosus (CLE) encompasses the complex interactions between genetics, the environment, and cells and their products. Recent data have provided enhanced understanding of these interactions and the mechanism by which they cause disease. A number of candidate genes have been identified which increase the
Achtman, Jordan C, Werth, Victoria P
openaire   +2 more sources

Capecitabine-Induced Subacute Cutaneous Lupus Erythematosus in a Patient with Systemic Lupus Erythematosus

open access: yes, 2018
Capecitabine is a fluoropyrimidine chemotherapy prodrug of 5-fluorouracil (5-FU) used in the treatment of metastatic breast and colorectal cancers.
Darwin, Evan   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy